NDC 88013-0001-01: Verrolis WART REMOVER 17 g/100mL Liquid, 30 mL Bottle
This is a package of 30 mL of Verrolis WART REMOVER 17 g/100mL Liquid from Putian Chufan Trading Co., Ltd., first listed with the FDA Sep 2026 and currently FDA-listed. It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 88013-001-01 alone.
- Record
- FDA NDC Directory package listing · Human OTC drug
- Code segments
- 88013 labeler · 001 product · 01 package
- Package marketed since
- Sep 15, 2026
- Sample package
- No — commercial package
- Listing certified through
- Dec 31, 2027
- Barcode (UPC-A, from the NDC)
- 3 8801300101 7
- FDA record last changed
- Nov 12, 2026
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
- RxCUI (RxNorm): 312881
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
RxNorm drug class
This medicine belongs to the Salicylic acid and derivatives class.
Where does this data come from?
- RxClass (NLM) · catalog refreshed Nov 19, 2026
Clinical
Topical salicylic acid is used to help clear and prevent pimples and skin blemishes in people who have acne. Topical salicylic acid is also used to treat skin conditions that involve scaling or overgrowth of skin cells such as psoriasis (a skin disease in which red, scaly patches form on some areas of the body), ichthyoses (inborn conditions that cause skin dryness and scaling), dandruff, corns, calluses, and warts on the hands or feet. Topical salicylic acid should not be used to treat genital warts, warts on the face, warts with hair growing from them, warts in the nose or mouth, moles, or b...
Read the full MedlinePlus article ↗Verrolis Wart Remover is a topical liquid containing salicylic acid, marketed as an over-the-counter monograph drug. Salicylic acid is commonly used in wart removal products to help break down and soften the outer layers of skin. This product is applied directly to the affected area as a liquid formulation and is intended for external use only.
Patient education
Supplement & herbal interactions
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | Not in the retail survey — common for institutional, discontinued, or low-volume packs. | |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 88013-0001-01 You're viewing this Main listing | 30 mL in 1 BOTTLE | 2026-09-15 | — | Active |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| OSNOIA Wart Remover 17 g/100mL 85150-0006-01 | Guangzhou | 15 ml | — | — | FDA listed | — |
| Wart Remover 17 g/100mL 87255-0003-01 | Shenzhen | 15 ml | — | — | FDA listed | — |
| BURRRER Wart Remover 17 g/100mL 85795-0001-01 | Shenzhen | 30 ml | — | — | FDA listed | — |
| Verrolis WART REMOVER 17 g/100mLthis 88013-0001-01 | Putian | 30 ml | — | — | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file
Availability & generic status
We did not find an FDA-approved generic match for this exact strength, form and route.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.
-
UNII 3K9958V90M
A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
-
UNII 33X04XA5AT
Lactic acid is a naturally occurring organic acid derived from milk or plant sources. It lowers and maintains pH in formulations, helps preserve the product, and can enhance ingredient stability and absorption.
-
UNII 50C1307PZG
Pentylene glycol is a humectant and preservative helper derived from petroleum or plant sources. It draws moisture into the product and helps prevent bacterial growth, keeping medicines stable during storage.
-
UNII 6DC9Q167V3
Propylene glycol is a clear liquid derived from petroleum or vegetable sources. It acts as a solvent, humectant, and preservative in medicines, helping dissolve active ingredients and maintain product stability.
-
UNII 059QF0KO0R
Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.
5 inactive ingredients listed in the exact product block matched to this NDC.
Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.
Where does this data come from?
ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
FDA label — Drug Facts FDA SPL
🎯 Indications and Usage ▾
Use For the removal of common warts. The common wart is easily recognized by the rough "cauliflower-like" appearance of the surface. For the removal of plantar warts on the bottom of the foot. The plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern.
⏱️ Dosage and Administration ▾
Directions Wash affected area. May soak wart in warm water for 5 minutes. Dry area thoroughly. Apply one drop at a time with brush to sufficiently cover each wart. Let dry. Repeat this procedure once or twice daily as needed until wart is removed or up to 12 weeks.
⚠️ Warnings ▾
Warnings For external use only.
📦 Storage and Handling ▾
Other information Store at 20-25°C (68-77°F). Keep bottle tightly closed. Protect from freezing. Avoid excessive heat or flame. Specification: 1 fl.oz/30ml. Made in China.
🧪 Active Ingredient ▾
Active Ingredient Salicylic acid 17% w/w
🧪 Inactive Ingredients ▾
Inactive ingredients Alcohol, propylene glycol, water, lactic acid, polyethylene glycol.
🎯 Purpose ▾
Purpose Wart remover
📄 Do Not Use ▾
Do not use On moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. On irritated skin or on any area that is infected or reddened. If you have diabetes or poor blood circulation.
📄 Ask a Doctor Before Use If ▾
Ask Doctor Stop use and ask a doctor if discomfort persists or excessive irritation occurs.
📄 When Using This Product ▾
When Using If product gets into the eye, flush with water for 15 minutes. Avoid inhaling vapor. Cap bottle tightly and store at room temperature away from heat.
📄 Stop Use and Ask a Doctor If ▾
Stop Use Stop use and ask a doctor if discomfort persists or excessive irritation occurs.
📄 Keep Out of Reach of Children ▾
Keep Out Of Reach Of Children Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.
📄 Package Label / Principal Display Panel ▾
PRINCIPAL DISPLAY PANEL 88013-001-01 1
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | ✓ Available |
| Package photos | ✓ Available |
| Inactive ingredients (structured) | ✓ Available |
| NADAC pharmacy acquisition price (CMS) | — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey. |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |